DermTech, Inc. Warrant
DMTKW
DMTKW was delisted on the 17th of October, 2019.
16 hedge funds and large institutions have $2.55M invested in DermTech, Inc. Warrant in 2019 Q3 according to their latest regulatory filings, with 16 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
BlueCrest Capital Management
St Helier,
Jersey
|
+$183K |
| 2 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
+$155K |
| 3 |
KC
Kepos Capital
New York
|
+$132K |
| 4 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
+$58.9K |
| 5 |
D.E. Shaw & Co
New York
|
+$37.8K |
Top Sellers
DMTKW Hedge Fund Activity: Q3 2019 in Review
16 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in DermTech, Inc. Warrant (DMTKW) for Q3 2019, worth a combined $2.55M.
Buyers outnumbered sellers: 16 funds opened new DMTKW positions and 0 closed out — a net gain of 16 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was BlueCrest Capital Management, opening a new position worth an estimated $183K.
- 16 institutional investors held DermTech, Inc. Warrant (DMTKW) as of Q3 2019, up from 0 in Q2 2019.
- Funds reported $2.55M of DermTech, Inc. Warrant stock for Q3 2019.
- 16 funds opened new DermTech, Inc. Warrant positions in Q3 2019 and 0 closed out, a net change of +16 holders.
- The largest DermTech, Inc. Warrant buyer in Q3 2019 was BlueCrest Capital Management, an estimated $183K added.
Based on aggregated 13F filings for Q3 2019.